Chapter 1: Introduction
1.1. Report Description
1.2. Key Benefits for Stakeholders
1.3. Key Market Segments
1.4. Research Methodology
1.4.1. Secondary Research
1.4.2. Primary Research
1.4.3. Analyst Tools and Models
Chapter 2: Executive Summary
2.1. Cxo Perspective
Chapter 3: Market Overview
3.1. Market Definition and Scope
3.2. Key Findings
3.2.1. Top Investment Pockets
3.2.2. Top Winning Strategies
3.2.3. Top Player Positioning, 2019
3.3. Porter’S Five Force Analysis
3.4. Market Dynamics
3.4.1. Drivers
3.4.1.1. Increase in Funding for R&D Activities Pertaining to Gene Therapy
3.4.1.2. The Rise in Prevalence of Cancer, Viral Infections, and Genetic Disorders
3.4.1.3. Increase in Awareness Regarding Gene Therapies
3.4.2. Restraints
3.4.2.1. High Cost Associated With Gene Therapies
3.4.2.2. Risk of Mutagenesis and Other Impediments in Gene Therapy
3.4.3. Opportunities
3.4.3.1. Increase in Demand for Synthetic Genes
3.4.3.2. Untapped Markets in Developing Economies
3.5. Covid-19 Impact Analysis for Viral Vector and Plasmid Dna Manufacturing Market
Chapter 4: Viral Vectors and Plasmid Dna Manufacturing Market, by Product
4.1. Overview
4.1.1. Market Size and Forecast
4.2. Viral Vectors
4.2.1. Key Market Trends, Growth Factors, and Opportunities
4.2.2. Market Size and Forecast, by Region
4.2.3. Market Analysis, by Country
4.3. Plasmid Dna
4.3.1. Key Market Trends, Growth Factors, and Opportunities
4.3.2. Market Size and Forecast, by Region
4.3.3. Market Analysis, by Country
4.4. Non-Viral Vectors
4.4.1. Key Market Trends, Growth Factors, and Opportunities
4.4.2. Market Size and Forecast, by Region
4.4.3. Market Analysis, by Country
Chapter 5: Viral Vectors and Plasmid Dna Manufacturing Market, by Application
5.1. Overview
5.1.1. Market Size and Forecast
5.2. Cancer
5.2.1. Market Size and Forecast, by Region
5.2.2. Market Analysis, by Country
5.3. Inherited Disorder
5.3.1. Market Size and Forecast, by Region
5.3.2. Market Analysis, by Country
5.4. Viral Infection
5.4.1. Market Opportunities Associated With Covid 19 Pandemic
5.4.2. Market Size and Forecast, by Region
5.4.3. Market Analysis, by Country
5.5. Others
5.5.1. Market Size and Forecast, by Region
5.5.2. Market Analysis, by Country
Chapter 6: Viral Vectors and Plasmid Dna Manufacturing Market, by Region
6.1. Overview
6.1.1. Market Size and Forecast
6.2. North America
6.2.1. Key Market Trends, Growth Factors, and Opportunities
6.2.2. North America Viral Vectors and Plasmid Dna Manufacturing Market , by Country
6.2.2.1. U. S. Viral Vectors and Plasmid Dna Manufacturing Market, by Product
6.2.2.2. U. S. Viral Vectors and Plasmid Dna Manufacturing Market, by Application
6.2.2.3. Canada Viral Vectors and Plasmid Dna Manufacturing Market, by Product
6.2.2.4. Canada Viral Vectors and Plasmid Dna Manufacturing Market, by Application
6.2.2.5. Mexico Viral Vectors and Plasmid Dna Manufacturing Market, by Product
6.2.2.6. Mexico Viral Vectors and Plasmid Dna Manufacturing Market, by Application
6.2.3. North America Viral Vectors and Plasmid Dna Manufacturing, by Product
6.2.4. North America Viral Vectors and Plasmid Dna Manufacturing, by Application
6.3. Europe
6.3.1. Key Market Trends, Growth Factors, and Opportunities
6.3.2. Europe Viral Vectors and Plasmid Dna Manufacturing, by Country
6.3.2.1. UK Viral Vectors and Plasmid Dna Manufacturing Market, by Product
6.3.2.2. UK Viral Vectors and Plasmid Dna Manufacturing Market, by Application
6.3.2.3. Germany Viral Vectors and Plasmid Dna Manufacturing Market, by Product
6.3.2.4. Germany Viral Vectors and Plasmid Dna Manufacturing Market, by Application
6.3.2.5. France Viral Vectors and Plasmid Dna Manufacturing Market, by Product
6.3.2.6. France Viral Vectors and Plasmid Dna Manufacturing Market, by Application
6.3.2.7. Italy Viral Vectors and Plasmid Dna Manufacturing Market, by Product
6.3.2.8. Italy Viral Vectors and Plasmid Dna Manufacturing Market, by Application
6.3.2.9. Spain Viral Vectors and Plasmid Dna Manufacturing Market, by Product
6.3.2.10. Spain Viral Vectors and Plasmid Dna Manufacturing Market, by Application
6.3.2.11. Rest of Europe Viral Vectors and Plasmid Dna Manufacturing Market, by Product
6.3.2.12. Rest of Europe Viral Vectors and Plasmid Dna Manufacturing Market, by Application
6.3.3. Europe Viral Vectors and Plasmid Dna Manufacturing, by Product
6.3.4. Europe Viral Vectors and Plasmid Dna Manufacturing, by Application
6.4. Asia-Pacific
6.4.1. Key Market Trends, Growth Factors, and Opportunities
6.4.2. Asia-Pacific Viral Vectors and Plasmid Dna Manufacturing Market, by Country
6.4.2.1. Japan Viral Vectors and Plasmid Dna Manufacturing Market, by Product
6.4.2.2. Japan Viral Vectors and Plasmid Dna Manufacturing Market, by Application
6.4.2.3. China Viral Vectors and Plasmid Dna Manufacturing Market, by Product
6.4.2.4. China Viral Vectors and Plasmid Dna Manufacturing Market, by Application
6.4.2.5. Australia Viral Vectors and Plasmid Dna Manufacturing Market, by Product
6.4.2.6. Australia Viral Vectors and Plasmid Dna Manufacturing Market, by Application
6.4.2.7. India Viral Vectors and Plasmid Dna Manufacturing Market, by Product
6.4.2.8. India Viral Vectors and Plasmid Dna Manufacturing Market, by Application
6.4.2.9. South Korea Viral Vectors and Plasmid Dna Manufacturing Market, by Product
6.4.2.10. South Korea Viral Vectors and Plasmid Dna Manufacturing Market, by Application
6.4.2.11. Taiwan Viral Vectors and Plasmid Dna Manufacturing Market, by Product
6.4.2.12. Taiwan Viral Vectors and Plasmid Dna Manufacturing Market, by Application
6.4.2.13. Rest of Asia-Pacific Viral Vectors and Plasmid Dna Manufacturing Market, by Product
6.4.2.14. Rest of Asia-Pacific Viral Vectors and Plasmid Dna Manufacturing Market, by Application
6.4.3. Asia-Pacific Viral Vectors and Plasmid Dna Manufacturing Market, by Product
6.4.4. Asia-Pacific Viral Vectors and Plasmid Dna Manufacturing Market, by Application
6.5. LAMEA
6.5.1. Key Market Trends, Growth Factors, and Opportunities
6.5.2. LAMEA Viral Vectors and Plasmid Dna Manufacturing Market, by Country
6.5.2.1. Brazil Viral Vectors and Plasmid Dna Manufacturing Market, by Product
6.5.2.2. Brazil Viral Vectors and Plasmid Dna Manufacturing Market, by Application
6.5.2.3. Saudi Arabia Viral Vectors and Plasmid Dna Manufacturing Market, by Product
6.5.2.4. Saudi Arabia Viral Vectors and Plasmid Dna Manufacturing Market, by Application
6.5.2.5. South Africa Viral Vectors and Plasmid Dna Manufacturing Market, by Product
6.5.2.6. South Africa Viral Vectors and Plasmid Dna Manufacturing Market, by Application
6.5.2.7. Rest of LAMEA Viral Vectors and Plasmid Dna Manufacturing Market, by Product
6.5.2.8. Rest of LAMEA Viral Vectors and Plasmid Dna Manufacturing Market, by Application
6.5.3. LAMEA Viral Vectors and Plasmid Dna Manufacturing Market, by Product
6.5.4. LAMEA Viral Vectors and Plasmid Dna Manufacturing Market, by Application
Chapter 7: Company Profiles
7.1. Cognate Bioservices, Inc.
7.1.1. Company Overview
7.1.2. Company Snapshot
7.1.3. Operating Business Segment
7.1.4. Product Portfolio
7.1.5. Key Strategic Moves and Developments
7.2. Catalent Pharma Solutions
7.2.1. Company Overview
7.2.2. Company Snapshot
7.2.3. Operating Business Segment
7.2.4. Product Portfolio
7.2.5. Business Performance
7.2.6. Key Strategic Moves and Developments
7.3. Fujifilm Holdings Corporation
7.3.1. Company Overview
7.3.2. Company Snapshot
7.3.3. Operating Business Segment
7.3.4. Product Portfolio
7.3.5. Business Performance
7.3.6. Key Strategic Moves and Developments
7.4. Johnson & Johnson
7.4.1. Company Overview
7.4.2. Company Snapshot
7.4.3. Operating Business Segment
7.4.4. Product Portfolio
7.4.5. Business Performance
7.4.6. Key Strategic Moves and Developments
7.5. F. Hoffmann-La Roche Ltd.
7.5.1. Company Overview
7.5.2. Company Snapshot
7.5.3. Operating Business Segment
7.5.4. Product Portfolio
7.5.5. Business Performance
7.5.6. Key Strategic Moves and Developments
7.6.4D Molecular Therapeutics
7.6.1. Company Overview
7.6.2. Company Snapshot
7.6.3. Operating Business Segment
7.6.4. Product Portfolio
7.6.5. Key Strategic Moves and Developments
7.7. Sanofi Corporation
7.7.1. Company Overview
7.7.2. Company Snapshot
7.7.3. Operating Business Segment
7.7.4. Product Portfolio
7.7.5. Business Performance
7.8. Sirion Biotech GmbH
7.8.1. Company Overview
7.8.2. Company Snapshot
7.8.3. Operating Business Segment
7.8.4. Product Portfolio
7.9. Thermo Fisher Scientific, Inc.
7.9.1. Company Overview
7.9.2. Company Snapshot
7.9.3. Operating Business Segment
7.9.4. Product Portfolio
7.9.5. Business Performance
7.9.6. Key Strategic Moves and Developments
7.10. Voyager Therapeutics Inc.
7.10.1. Company Overview
7.10.2. Company Snapshot
7.10.3. Operating Business Segment
7.10.4. Product Portfolio
7.10.5. Business Performance
7.10.6. Key Strategic Moves and Developments
List of Tables
Table 01. Viral Vectors and Plasmid Dna Manufacturing Market, by Product, 2019-2027 ($Million)
Table 02. Viral Vectors and Plasmid Dna Manufacturing Market, by Viral Vectors, by Region, 2019-2027 ($Million)
Table 03. Viral Vectors and Plasmid Dna Manufacturing Market, by Plasmid Dnas, by Region, 2019-2027 ($Million)
Table 04. Viral Vectors and Plasmid Dna Manufacturing Market, by Non-Viral Vectors, by Region, 2019-2027 ($Million)
Table 05. Viral Vectors and Plasmid Dna Manufacturing Market, by Application, 2019-2027 ($Million)
Table 06. Viral Vectors and Plasmid Dna Manufacturing Market, by Cancer, by Region, 2019-2027 ($Million)
Table 07. Viral Vectors and Plasmid Dna Manufacturing Market, by Inherited Disorders, by Region, 2019-2027 ($Million)
Table 08. Viral Vectors and Plasmid Dna Manufacturing Market, by Viral Infection, by Region, 2019-2027 ($Million)
Table 09. Viral Vectors and Plasmid Dna Manufacturing Market, by Others, by Region, 2019-2027 ($Million)
Table 10. Global Viral Vectors and Plasmid Dna Manufacturing Market Revenue, by Region, 2019-2027 ($Million)
Table 11. North America Viral Vectors and Plasmid Dna Manufacturing, by Country, 2019-2027 ($Million)
Table 12. U.S. Viral Vectors and Plasmid Dna Manufacturing, by Product, 2019-2027 ($Million)
Table 13. U.S. Viral Vectors and Plasmid Dna Manufacturing, by Application, 2019-2027 ($Million)
Table 14. Canada Viral Vectors and Plasmid Dna Manufacturing, by Product, 2019-2027 ($Million)
Table 15. Canada Viral Vectors and Plasmid Dna Manufacturing, by Application, 2019-2027 ($Million)
Table 16. Mexico Viral Vectors and Plasmid Dna Manufacturing, by Product, 2019-2027 ($Million)
Table 17. Mexico Viral Vectors and Plasmid Dna Manufacturing, by Application, 2019-2027 ($Million)
Table 18. North America Viral Vectors and Plasmid Dna Manufacturing, by Product, 2019-2027 ($Million)
Table 19. North America Viral Vectors and Plasmid Dna Manufacturing, by Application, 2019-2027 ($Million)
Table 20. Europe Viral Vectors and Plasmid Dna Manufacturing, by Country, 2019-2027 ($Million)
Table 21. UK Viral Vectors and Plasmid Dna Manufacturing, by Product, 2019-2027 ($Million)
Table 22. UK Viral Vectors and Plasmid Dna Manufacturing, by Application, 2019-2027 ($Million)
Table 23. Germany Viral Vectors and Plasmid Dna Manufacturing, by Product, 2019-2027 ($Million)
Table 24. Germany Viral Vectors and Plasmid Dna Manufacturing, by Application, 2019-2027 ($Million)
Table 25. France Viral Vectors and Plasmid Dna Manufacturing, by Product, 2019-2027 ($Million)
Table 26. France Viral Vectors and Plasmid Dna Manufacturing, by Application, 2019-2027 ($Million)
Table 27. Italy Viral Vectors and Plasmid Dna Manufacturing, by Product, 2019-2027 ($Million)
Table 28. Italy Viral Vectors and Plasmid Dna Manufacturing, by Application, 2019-2027 ($Million)
Table 29. Spain Viral Vectors and Plasmid Dna Manufacturing, by Product, 2019-2027 ($Million)
Table 30. Spain Viral Vectors and Plasmid Dna Manufacturing, by Application, 2019-2027 ($Million)
Table 31. Rest of Europe Viral Vectors and Plasmid Dna Manufacturing, by Product, 2019-2027 ($Million)
Table 32. Rest of Europe Viral Vectors and Plasmid Dna Manufacturing, by Application, 2019-2027 ($Million)
Table 33. Europe Viral Vectors and Plasmid Dna Manufacturing, by Product, 2019-2027 ($Million)
Table 34. Europe Viral Vectors and Plasmid Dna Manufacturing, by Application, 2019-2027 ($Million)
Table 35. Asia-Pacific Viral Vectors and Plasmid Dna Manufacturing Market, by Country, 2019-2027 ($Million)
Table 36. Japan Viral Vectors and Plasmid Dna Manufacturing Market, by Product, 2019-2027 ($Million)
Table 37. Japan Viral Vectors and Plasmid Dna Manufacturing Market, by Application, 2019-2027 ($Million)
Table 38. China Viral Vectors and Plasmid Dna Manufacturing Market, by Product, 2019-2027 ($Million)
Table 39. China Viral Vectors and Plasmid Dna Manufacturing Market, by Application, 2019-2027 ($Million)
Table 40. Australia Viral Vectors and Plasmid Dna Manufacturing Market, by Product, 2019-2027 ($Million)
Table 41. Australia Viral Vectors and Plasmid Dna Manufacturing Market, by Application, 2019-2027 ($Million)
Table 42. India Viral Vectors and Plasmid Dna Manufacturing Market, by Product, 2019-2027 ($Million)
Table 43. India Viral Vectors and Plasmid Dna Manufacturing Market, by Application, 2019-2027 ($Million)
Table 44. South Korea Viral Vectors and Plasmid Dna Manufacturing Market, by Product, 2019-2027 ($Million)
Table 45. South Korea Viral Vectors and Plasmid Dna Manufacturing Market, by Application, 2019-2027 ($Million)
Table 46. Taiwan Viral Vectors and Plasmid Dna Manufacturing Market, by Product, 2019-2027 ($Million)
Table 47. Taiwan Viral Vectors and Plasmid Dna Manufacturing Market, by Application, 2019-2027 ($Million)
Table 48. Rest of Asia-Pacific Viral Vectors and Plasmid Dna Manufacturing Market, by Product, 2019-2027 ($Million)
Table 49. Rest of Asia-Pacific Viral Vectors and Plasmid Dna Manufacturing Market, by Application, 2019-2027 ($Million)
Table 50. Asia-Pacific Viral Vectors and Plasmid Dna Manufacturing Market, by Product, 2019-2027 ($Million)
Table 51. Asia-Pacific Viral Vectors and Plasmid Dna Manufacturing Market, by Application, 2019-2027 ($Million)
Table 52. LAMEA Viral Vectors and Plasmid Dna Manufacturing Market, by Country, 2019-2027 ($Million)
Table 53. Brazil Viral Vectors and Plasmid Dna Manufacturing Market, by Product, 2019-2027 ($Million)
Table 54. Brazil Viral Vectors and Plasmid Dna Manufacturing Market, by Application, 2019-2027 ($Million)
Table 55. Saudi Arabia Viral Vectors and Plasmid Dna Manufacturing Market, by Product, 2019-2027 ($Million)
Table 56. Saudi Arabia Viral Vectors and Plasmid Dna Manufacturing Market, by Application, 2019-2027 ($Million)
Table 57. South Africa Viral Vectors and Plasmid Dna Manufacturing Market, by Product, 2019-2027 ($Million)
Table 58. South Africa Viral Vectors and Plasmid Dna Manufacturing Market, by Application, 2019-2027 ($Million)
Table 59. Rest of LAMEA Viral Vectors and Plasmid Dna Manufacturing Market, by Product, 2019-2027 ($Million)
Table 60. Rest of LAMEA Viral Vectors and Plasmid Dna Manufacturing Market, by Application, 2019-2027 ($Million)
Table 61. LAMEA Viral Vectors and Plasmid Dna Manufacturing Market, by Product, 2019-2027 ($Million)
Table 62. LAMEA Viral Vectors and Plasmid Dna Manufacturing Market, by Application, 2019-2027 ($Million)
Table 63. Cognate: Company Snapshot
Table 64. Cognate: Oerating Segment
Table 65. Cognate: Product Portfolio
Table 66. Cognate: Key Strategic Moves and Developments
Table 67. Catalent: Company Snapshot
Table 68. Catalent: Operating Segments
Table 69. Catalent: Product Portfolio
Table 70. Catalent: Key Strategic Moves and Developments
Table 71. Fujifilm: Company Snapshot
Table 72. Fujifilm: Operating Business Segment
Table 73. Fujifilm: Product Portfolio
Table 74. J&J: Company Snapshot
Table 75. J&J: Operating Business Segment
Table 76. J&J: Product Portfolio
Table 77. Roche: Company Snapshot
Table 78. Roche: Operating Segments
Table 79. Roche: Product Portfolio
Table 80. 4D: Company Snapshot
Table 81. 4D: Operating Segments
Table 82. 4D: Product Portfolio
Table 83. Sanofi: Company Snapshot
Table 84. Sanofi: Operating Segments
Table 85. Sanofi: Product Portfolio
Table 86. Sirion: Company Snapshot
Table 87. Sirion: Operating Segments
Table 88. Sirion: Product Portfolio
Table 89. Thermo Fisher Scientific.: Company Snapshot
Table 90. Thermo Fisher Scientific: Product Segment
Table 91. Thermo Fisher Scientific: Product Portfolio
Table 92. Voyager: Company Snapshot
Table 93. Voyager: Product Portfolio
Table 94. Voyager: Key Strategic Moves and Developments
List of Figures
Figure 01. Viral Vectors and Plasmid Dna Manufacturing Market Segmentation
Figure 02. Top Investment Pockets
Figure 03. Top Winning Strategies, 2017-2020
Figure 04. Top Winning Strategies: Nature and Type, 2017-2020
Figure 05. Top Winning Strategies: by Year, 2017-2020
Figure 06. Top Player Positioning, 2019
Figure 07. Moderate Bargaining Power of Suppliers
Figure 08. High Bargaining Power of Buyers
Figure 09. High Threat of Substitutes
Figure 10. Moderate Threat of New Entrants
Figure 11. Moderate Competitive of Rivalry
Figure 12. Driver, Restrainsts and Opportunities
Figure 13. Comparative Analysis of Viral Vectors and Plasmid Dna Manufacturing Market, by Viral Vectors, by Region, 2019-2027 ($Million)
Figure 14. Comparative Analysis of Viral Vectors and Plasmid Dna Manufacturing Market, by Plasmid Dnas, by Region, 2019-2027 ($Million)
Figure 15. Comparative Analysis of Viral Vectors and Plasmid Dna Manufacturing Market, by Non-Viral Vectors, by Region, 2019-2027 ($Million)
Figure 16. Comparative Analysis of Viral Vectors and Plasmid Dna Manufacturing Market, by Cancers, by Region, 2019-2027 ($Million)
Figure 17. Comparative Analysis of Viral Vectors and Plasmid Dna Manufacturing Market, by Inherited Disorders, by Region, 2019-2027 ($Million)
Figure 18. Comparative Analysis of Viral Vectors and Plasmid Dna Manufacturing Market, by Viral Infection, by Region, 2019-2027 ($Million)
Figure 19. Comparative Analysis of Viral Vectors and Plasmid Dna Manufacturing Market, by Others, by Region, 2019-2027 ($Million)
Figure 20. Catalent: Net Sales, 2017-2019 ($Million)
Figure 21. Catalent: Revenue Share, by Segment, 2019 (%)
Figure 22. Catalent: Revenue Share, by Region, 2019 (%)
Figure 23. Fujifilm: Net Sales, 2017-2019 ($Million)
Figure 24. Fujifilm: Revenue Share, by Segment, 2019 (%)
Figure 25. J&J: Net Sales, 2017-2019 ($Million)
Figure 26. J&J: Revenue Share, by Segment, 2019 (%)
Figure 27. J&J: Revenue Share, by Region, 2019 (%)
Figure 28. Roche: Net Sales, 2017-2019 ($Million)
Figure 29. Roche: Revenue Share, by Segment, 2019 (%)
Figure 30. Roche: Revenue Share, by Region, 2019 (%)
Figure 31. Sanofi: Net Sales, 2017-2019 ($Million)
Figure 32. Sanofi: Revenue Share, by Segment, 2019 (%)
Figure 33. Sanofi: Revenue Share, by Region, 2019 (%)
Figure 34. Thermo Fisher Scientific, Inc. : Net Sales, 2017-2019 ($Million)
Figure 35. Thermo Fisher Scientific, Inc. : Revenue Share, by Segment, 2019 (%)
Figure 36. Thermo Fisher Scientific. Revenue Share, by Region, 2019 (%)
Figure 37. Voyager: Net Sales, 2017-2019 ($Million)